QQ客服 官方微博 反馈留言

	Compound; composition; method of treating and/or preventing migraine, SRA, Alzheimer' s disease, Parkinson' s disease, disorders EXTRAPIRIMIDAIS, depression, nausea, êmese, restless legs syndrome, insomnia, insult, huntington' s disease, cardiopulmonary disease, fibrogênese, pulmonary hypertension occlusion, anxiety, drug dependence, dystonia, or in a subject PARASSONIAHIPERLACTINEMIA; methods of agoniza??o d2 receptors, 5 it ht1d, 5 it ht1a and 5 it ht2c, in a subject; method of antagonizing d3 receptor in a subject; methods of selective agoniza??o receptors 5 it ht1d, and 5 it ht2c, method of providing functional antagonist activity in the receiver in the receiver or 5 it ht2b 5 it ht7, or both, in a subject; method of providing functional antagonist activity in the receptors in a subject adrenergic
	THOMAS ARMER; GEOFF MCKINLEY; SCOTT BORLAND; MIGUEL GUZMAN; ARMIN SZABOLCS; JANOS GERENCSER
URL标识	查看原文
语种	中文
内容类型	专利
URI标识	http://www.corc.org.cn/handle/1471x/3577230
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	THOMAS ARMER,GEOFF MCKINLEY,SCOTT BORLAND,et al. Compound; composition; method of treating and/or preventing migraine, SRA, Alzheimer' s disease, Parkinson' s disease, disorders EXTRAPIRIMIDAIS, depression, nausea, êmese, restless legs syndrome, insomnia, insult, huntington' s disease, cardiopulmonary disease, fibrogênese, pulmonary hypertension occlusion, anxiety, drug dependence, dystonia, or in a subject PARASSONIAHIPERLACTINEMIA; methods of agoniza??o d2 receptors, 5 it ht1d, 5 it ht1a and 5 it ht2c, in a subject; method of antagonizing d3 receptor in a subject; methods of selective agoniza??o receptors 5 it ht1d, and 5 it ht2c, method of providing functional antagonist activity in the receiver in the receiver or 5 it ht2b 5 it ht7, or both, in a subject; method of providing functional antagonist activity in the receptors in a subject adrenergic.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。